Provided By GlobeNewswire
Last update: Sep 17, 2025
EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of HilleVax, Inc. (NASDAQ: HLVX) (“HilleVax”) common stock for a price per share of $1.95 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and together with the Cash Amount, the “Offer Price”).
Read more at globenewswire.comNASDAQ:XOMA (9/30/2025, 12:45:13 PM)
38
+0.8 (+2.15%)
XOMA ROYALTY CORP - XOMA 8 5/8 PERP
NASDAQ:XOMAP (9/30/2025, 9:34:44 AM)
26.12
-0.16 (-0.63%)
XOMA ROYALTY CORP - XOMA 8 3/8 PERP
NASDAQ:XOMAO (9/30/2025, 12:11:12 PM)
25.65
-0.02 (-0.08%)
Find more stocks in the Stock Screener